Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 24;18(6):1525-1534.
doi: 10.5114/aoms/136518. eCollection 2022.

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review

Chunfeng Wu  1 , Liling Li  1 , Jiarong Zhang  1 , Yang Song  1
Affiliations
Review

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review

Chunfeng Wu et al. Arch Med Sci. .

Abstract

Introduction: The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to provide evidence for clinical PE management.

Material and methods: We searched PubMed and other databases for randomized controlled trials (RCTs) on the effects and safety of low-dose aspirin and LMWH in the treatment of PE up to January 31, 2021. Two researchers strictly followed the inclusion and exclusion criteria to independently conduct the literature screening, data extraction and quality evaluation. We used RevMan 5.3 statistical software for synthesized analysis.

Results: A total of 8 RCTs involving 861 patients were included. The synthesized outcome indicated that the differences in systolic blood pressure (MD = -10.61, 95% CI: -13.19 - -8.02), diastolic blood pressure (MD = -9.24, 95% CI: -14.49- -4.00), 24-hour urinary protein (MD = -2.24, 95% CI: -3.97- -0.50), prothrombin time (MD = 1.42, 95% CI: 0.53-2.32), activated partial thromboplastin time (MD = 2.91, 95% CI: 2.06-3.75), FIB (MD = -1.24, 95% CI: -1.32- -1.15), and adverse perinatal outcomes (MD = 0.41, 95% CI: 0.20-0.85) between the two groups were statistically significant (all p < 0.05), while the difference in the adverse reactions of pregnant women (MD = 0.44, 95% CI: 0.18-1.10) between the two groups was not statistically significant (p = 0.08). No publication bias was detected in all the synthesized outcomes (all p > 0.05).

Conclusions: Low-dose aspirin combined with LMWH treatment of PE may be advantageous to improve blood pressure, 24-hour proteinuria and coagulation function, and it may reduce the adverse reactions in pregnant women without increasing adverse perinatal outcomes.

Keywords: aspirin; dose; low-molecular-weight heparin; meta-analysis; preeclampsia; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram of study inclusion
Figure 2
Figure 2
Risk of bias graph
Figure 3
Figure 3
Risk of bias summary
Figure 4
Figure 4
Forest plot for synthesized outcomes
Figure 5
Figure 5
Forest plot for synthesized outcomes
Figure 6
Figure 6
Funnel plot for synthesized outcomes
See this image and copyright information in PMC

References

    1. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019; 124: 1094-112. - PubMed
    1. Filipek A, Jurewicz E. Preeclampsia – a disease of pregnant women. Postepy Biochem 2018; 64: 232-29. - PubMed
    1. Auger N, Low N, Paradis G, Ayoub A, Fraser WD. Preeclampsia and the longitudinal risk of hospitalization for depression at 28 years. Soc Psychiatry Psychiatr Epidemiol 2021; 56: 429-36. - PubMed
    1. Cuckle H. Screening for early-onset preeclampsia. Am J Obstet Gynecol 2021; 224: 246. - PubMed
    1. DeCarlo C, Boitano LT, Molina RL, et al. . Pregnancy and preeclampsia are associated with acute adverse peripheral arterial events. Arterioscler Thromb Vasc Biol 2021; 41: 526-33. - PubMed